News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
677,819 Results
Type
Article (38731)
Company Profile (247)
Press Release (638841)
Section
Business (203485)
Career Advice (1974)
Deals (35364)
Drug Delivery (77)
Drug Development (80531)
Employer Resources (167)
FDA (15979)
Job Trends (14773)
News (343534)
Policy (32410)
Tag
Academia (2530)
Africa (710)
Alliances (48989)
Alzheimer's disease (1132)
Approvals (15925)
Arizona (169)
Artificial intelligence (64)
Asia (36717)
Australia (5971)
Bankruptcy (351)
Best Places to Work (11209)
Biosimilars (60)
Biotechnology (170)
C2C Services and Suppliers (78914)
California (1520)
Canada (829)
Cancer (319)
Career advice (1644)
Cell therapy (96)
China (109)
Clinical research (62889)
Collaboration (105)
Colorado (63)
Connecticut (59)
COVID-19 (2471)
Cystic fibrosis (71)
Data (124)
Diabetes (64)
Diagnostics (5944)
Drug pricing (59)
Earnings (83623)
Employer resources (140)
Europe (78479)
Events (107366)
Executive appointments (86)
FDA (16143)
Florida (207)
Funding (91)
Gene therapy (73)
GLP-1 (497)
Government (4284)
Healthcare (18569)
Hotbed/Location (481311)
Idaho (56)
Illinois (230)
Indiana (133)
Infectious disease (2495)
Inflammatory bowel disease (86)
Interviews (305)
IPO (16163)
Job creations (3619)
Job search strategy (1411)
Kansas (93)
Layoffs (388)
Legal (7829)
Lung cancer (69)
Manufacturing (71)
Maryland (336)
Massachusetts (1273)
Medical device (13013)
Medtech (13016)
Mergers & acquisitions (19004)
Metabolic disorders (213)
Michigan (114)
Minnesota (201)
Neuroscience (1241)
New Jersey (468)
New York (476)
NextGen Class of 2024 (6480)
Non-profit (4452)
North Carolina (554)
Northern California (693)
Obesity (132)
Ohio (96)
Opinion (167)
Patents (55)
Pennsylvania (511)
People (55728)
Pharmaceutical (59)
Phase I (19480)
Phase II (27699)
Phase III (20701)
Pipeline (91)
Postmarket research (2545)
Preclinical (8291)
Press Release (64)
Rare diseases (111)
Real estate (5882)
Recruiting (63)
Regulatory (21133)
Research institute (2301)
Resumes & cover letters (345)
South America (1086)
Southern California (624)
Startups (3559)
Texas (179)
United States (7261)
Vaccines (443)
Washington State (232)
Weight loss (116)
Date
Last 7 days (461)
Last 30 days (2176)
Last 365 days (37412)
2024 (24439)
2023 (40083)
2022 (51179)
2021 (55721)
2020 (54095)
2019 (46557)
2018 (35022)
2017 (32124)
2016 (31492)
2015 (37569)
2014 (31344)
2013 (26376)
2012 (28599)
2011 (29290)
2010 (27359)
677,819 Results for "perseptive biosystems inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Genetown
T2 Biosystems Announces Commercial Expansion Through Hong Kong and Macau Distributor
T2 Biosystems, Inc., a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistant genes, announced the execution of a territory exclusive distribution agreement in Hong Kong and Macau.
June 25, 2024
·
4 min read
Genetown
T2 Biosystems Announces the Conversion of an Additional $15 Million of CRG Term Loan into Equity
T2 Biosystems, Inc., a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced the conversion of an additional $15 million of its term loan with entities affiliated with CRG Servicing LLC into T2 Biosystems equity.
May 6, 2024
·
4 min read
Genetown
T2 Biosystems Announces Commercial Expansion Through Middle East Distributor
T2 Biosystems, Inc., a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistant genes, announced the execution of a territory exclusive distribution agreement in Qatar.
May 6, 2024
·
5 min read
Business
T2 Biosystems Announces First Quarter 2024 Financial Results
T2 Biosystems, Inc., a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced unaudited financial and operational results for the first quarter ended March 31, 2024.
May 6, 2024
·
10 min read
Deals
T2 Biosystems Regains Compliance with Nasdaq Continued Listing Requirements
T2 Biosystems, Inc. today announced that it received written notice from the Nasdaq Stock Market LLC (“Nasdaq”) on May 21, 2024 informing the Company that it has regained compliance with the market value of listed securities (“MVLS”) requirement, as set forth in Nasdaq Listing Rule 5550(b)(2) (the “Rule”).
May 22, 2024
·
4 min read
Business
T2 Biosystems Announces Letter of Intent to Enter Strategic Partnership for Lyme Disease
T2 Biosystems, Inc. announced that it has signed a non-binding letter of intent to enter into a strategic partnership with ECO Laboratory, a Massachusetts-based clinical laboratory certified under the Clinical Laboratory Improvement Amendments.
May 7, 2024
·
6 min read
Business
T2 Biosystems to Report First Quarter 2024 Financial Results and Business Updates on May 6, 2024
T2 Biosystems, Inc. announced today that it will report financial results for the first quarter 2024 and business updates after market close on Monday, May 6, 2024.
April 24, 2024
·
1 min read
Genetown
T2 Biosystems Announces CRG’s Conversion from Preferred Stock to Common Stock - May 14, 2024
T2 Biosystems, Inc., a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced that entities affiliated with CRG Servicing LLC have converted Series A and Series B Convertible Preferred Stock to Common Stock.
May 14, 2024
·
4 min read
Deals
T2 Biosystems Receives Extension to Comply with Nasdaq Listing Requirement
T2 Biosystems, Inc. today announced that the Nasdaq Hearings Panel has granted the Company’s request for continued listing on the Nasdaq Stock Market.
March 12, 2024
·
4 min read
Business
Rapid Micro Biosystems Reports First Quarter 2024 Financial Results
Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced its financial results for the first quarter ended March 31, 2024.
May 3, 2024
·
9 min read
1 of 67,782
Next
